US Stock MarketDetailed Quotes

Regeneron Pharmaceuticals (REGN)

Watchlist
  • 805.970
  • +7.980+1.00%
Close Aug 13 15:59 ET
  • 805.970
  • 0.0000.00%
Pre 04:00 ET
82.98BMarket Cap19.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals (REGN) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q2
Stock NameRevenueRatio
Collaboration revenue2.46B57.22%
EYLEA HD ®596.3M13.90%
EYLEA ®412.2M9.61%
Libtayo ®342.6M7.98%
Other revenue193.3M4.51%
Libtayo146.8M3.42%
Praluent ®74.7M1.74%
Evkeeza ®53.3M1.24%
Lynozyfic ®16.5M0.38%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Collaboration revenue7.33B51.11%
United States5.79B40.38%
Other revenue702.6M4.90%
Libtayo - Rest of World507.5M3.54%
Other products10.1M0.07%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +13.72%
Sample Name
Sample Code
 +8.88%
Sample Name
Sample Code
 +7.65%
4
United Sts Brent Oil Fd Lp Unit
BNO
+6.33%
5
United States Oil Fund LP
USO
+4.80%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.66%
Sample Name
Sample Code
 +13.99%
Sample Name
Sample Code
 +9.20%
4
Hesai
HSAI
+8.68%
5
Pony AI
PONY
+7.07%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -